Mini Invasive Floating Metatarsal Osteotomy for Diabetic Foot Ulcers Under the First Metatarsal Head: A Case Series.


Journal

The international journal of lower extremity wounds
ISSN: 1552-6941
Titre abrégé: Int J Low Extrem Wounds
Pays: United States
ID NLM: 101128359

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 20 6 2020
medline: 28 4 2022
entrez: 20 6 2020
Statut: ppublish

Résumé

Diabetic foot ulcers under the first metatarsal head are difficult to treat and prevent recurrence. The aim of this study is to summarize the results of a distal first metatarsal minimally invasive floating osteotomy for ulcers under the first metatarsal head in patients with diabetic neuropathy. We reviewed files of patients with diabetic neuropathy undergoing a floating first metatarsal osteotomy. Demographic and clinical data were collected and analyzed to determine success and complications. We found records for 21 patients (mean age 64) with University of Texas 1A ulcers. The ulcer's mean age was 11.2 months. Following surgery, the ulcer completely resolved after a mean of 3.7 (2 to 11) weeks in 19 patients. During the first year, there were 4 complications related to the surgery (including 3 infections). At latest follow-up, 17/21 (81%) patients had healed with satisfactory results. Minimal invasive floating distal osteotomy of the first metatarsal can cure and prevent recurrence of diabetic foot ulcers under the first metatarsal head in 80% of the patients, but the ability to provide close follow-up and prompt response are prerequisites.

Identifiants

pubmed: 32552348
doi: 10.1177/1534734620934579
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

131-136

Auteurs

Eran Tamir (E)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.
Maccabi Health Services, Tel Aviv, Israel.

Yossi Smorgick (Y)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.

Guy Zvi Ron (GZ)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.

Ron Gilat (R)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.

Gabriel Agar (G)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.

Aharon S Finestone (AS)

Shamir Medical Center, Zerifin, Israel.
Tel Aviv University, Tel Aviv, Israel.
Maccabi Health Services, Tel Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH